Live Market Update
GMP last updated on 14 Dec 2025, 12:18 pm. Trends are volatile.
Invicta Diagnostic IPO GMP Today, Live Trends & Listing Price
Invicta Diagnostic IPO GMP is currently trading at ₹17.65% per equity share. With a price band of 80-85, the estimated listing price is ₹102.65, suggesting a potential gain of 20.8% per share.
Current GMP
₹17.65%
(Today)
Est. Listing Price
₹102.65
(Cap Price + GMP)
Listing Gain
20.8%
(Expected)
Est. Profit/Lot
₹28,240
(1 Lot = 1600 Shares)
Invicta Diagnostic IPO GMP Day-by-Day History
Tracking the Grey Market Premium history helps in understanding the market sentiment trend. An increasing trend usually signals strong demand.
| GMP Date | GMP Value | Est. Listing Price (Gain) |
|---|---|---|
| No GMP history available yet. | ||
Quick IPO Details
- Open Date 1 Dec 2025
- Close Date 3 Dec 2025
- Offer Price 80-85
- Lot Size 1600 Shares
- Issue Size 33,08,800 shares(aggregating up to ₹28.12 crore)
- Listing At 8 Dec 2025
Frequently Asked Questions
What is the IPO GMP of Invicta Diagnostic today?
The Grey Market Premium (GMP) of Invicta Diagnostic IPO today is ₹17.65% per share.
What is the estimated listing price of Invicta Diagnostic IPO?
Based on the current GMP, the estimated listing price is ₹102.65 (Cap Price + GMP).
What is the expected profit per lot for Invicta Diagnostic IPO?
The expected profit per lot is around ₹28,240 (assuming the GMP remains stable until listing).
Is GMP reliable for listing gain prediction?
GMP is an unofficial market sentiment indicator and is not regulated. While it often indicates demand, it can change rapidly and should not be the sole basis for investment decisions.
How is IPO GMP calculated?
GMP is determined by the demand and supply of the IPO shares in the unregulated grey market. High demand usually leads to a higher GMP.
Disclaimer
The Grey Market Premium (GMP) reflects the unofficial market sentiment and is not an official listing price. Values change volatilely and based on market demand. IPO prices and listing gains are subject to market risks. Please consult a financial advisor before investing. We do not facilitate any grey market trading.
Written By
Mary Carter
Senior Analyst
asda